Last updated on: 9/24/2007 | Author:

Nathaniel Milton, PhD Biography

Clinical Neuroscience Researcher at London's Royal Free and University College Medical School
Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"

“I have shown that cannabinoids including noladin ether and anandamide are neuroprotective against amyloid-ß [chemical deposits in the brain].

The protective mechanism is mediated via cannabinoid CB1 receptor activation of p42/p44 kinase pathways [signaling pathways in the brain].”

Alzheimer’s Research Forum, Aug 28, 2006

Involvement and Affiliations:
  • Clinical Neuroscience Researcher, London’s Royal Free and University College Medical School
  • Co-founder and Research Director, NeuroDelta Ltd., 2003-present
  • Research Director, Insight Biotechnology Ltd., 1996-2004
  • Winner, University College London Entrepreneur’s Challenge competition, 2003
  • PhD, school unknown
  • None found